Orchestra BioMed Holdings (OBIO) Change in Acquisitions & Divestments (2023 - 2026)

Orchestra BioMed Holdings (OBIO) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $4.7 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 70.42% year-over-year to $4.7 million in Q1 2026; TTM through Mar 2026 was $38.6 million, a 47.17% decrease from a year earlier, with the FY2025 full-year figure at $49.9 million, down 42.44% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $4.7 million, down from $8.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for OBIO reached as high as $51.5 million in Q3 2023 and fell as low as $4.7 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $20.9 million across 4 years, with a median of $16.4 million in 2025.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 79.39% in 2024 and fell 10.42% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $37.1 million in 2023, then sank by 53.57% to $17.2 million in 2024, then plunged by 53.85% to $8.0 million in 2025, then slumped by 40.43% to $4.7 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $4.7 million in Q1 2026, $8.0 million in Q4 2025, and $9.5 million in Q3 2025.